Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.
“This is the most common muscle disease in boys, and there is currently no effective therapy,” saidDongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. “This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease.”
Patients with Duchenne muscular dystrophy have a gene mutation that disrupts the production of a protein known as “dystrophin.” Absence of dystrophin starts a chain reaction that eventually leads to muscle cell degeneration and death. Affected boys lose their ability to walk and breathe as they get older. This places significant limitations on individuals afflicted with the disease. Dystrophin also is one of the largest genes in the human body.
“Due to its size, it is impossible to deliver the entire gene with a gene therapy vector, which is the vehicle that carries the therapeutic gene to the correct site in the body,” Duan said. “Through previous research, we were able to develop a miniature version of this gene called a microgene. This minimized dystrophin protected all muscles in the body of diseased mice.”
However, it took the team more than 10 years to develop a strategy that can safely send the micro-dystrophin to every muscle in a dog that is afflicted by the disease. The dog has a body size similar to that of an affected boy. Success in the dog will set the foundation for human tests.
In this latest study, the MU team demonstrated for the first time that a common virus can deliver the microgene to all muscles in the body of a diseased dog. The dogs were injected with the virus when they were two to three months old and just starting to show signs of DMD. The dogs are now six to seven months old and continue to develop normally.
“The virus we are using is one of the most common viruses; it is also a virus that produces no symptoms in the human body, making this a safe way to spread the dystrophin gene throughout the body,” Duan said. “These dogs develop DMD naturally in a similar manner as humans. It’s important to treat DMD early before the disease does a lot of damage as this therapy has the greatest impact at the early stages in life.”
The Latest on: Muscular Dystrophy
[google_news title=”” keyword=”Muscular Dystrophy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Muscular Dystrophy
- Sarepta’s Duchenne Gene Therapy Elevidys Nabs $200M on Strong Demandon February 29, 2024 at 6:19 am
Sarepta Therapeutics on Wednesday called the launch of the gene therapy for Duchenne muscular dystrophy “exceptional” but the company does not expect to see significant growth in the first half of ...
- Destroy Duchenne selects DNA Nanobots as Partner to Develop Non-Viral Gene Delivery Solution for Duchenne Muscular Dystrophyon February 29, 2024 at 5:00 am
DNA Nanobots was Selected by Destroy Duchenne to Develop a Targeted Non-Viral Gene Delivery Solution for Duchenne Muscular Dystrophy.
- Muscular Dystrophy Association Applauds Landmark Proposal on Accessible Air Travel at The White Houseon February 29, 2024 at 4:18 am
MDA Advocacy #AccessibleAirTravel campaign celebrates crucial milestone for disability community. Applauds Landmark Proposal on Accessible Air Travel at The White House MDA Advocacy ...
- Medicine: Good Fighton February 28, 2024 at 12:39 pm
Muscular dystrophy, a progressive wasting of muscle power for whichneither cause nor cure is known, has a way of attacking families.George Anderson of Metuchen, ...
- Smartphone Tech Reveals Gait Differences in Duchenne Muscular Dystrophyon February 28, 2024 at 11:30 am
Outside of a gait laboratory, this investigation compared gait pattern differences between children who have Duchenne muscular dystrophy (DMD) and their typically developing counterparts to gain more ...
- Edmonton firefighters camp out in the cold for Muscular Dystrophy Canadaon February 27, 2024 at 2:04 pm
Six firefighters with Edmonton Fire Rescue Services are camping out on the rooftop of Station 2 in the city's downtown, in an effort to make a difference for families affected by muscular dystrophy.
- Capricor Therapeutics Granted Type-B Meeting With FDA For CAP-1002 Muscular Dystrophy Drug, Stock Upon February 27, 2024 at 2:32 am
Earlier, CAP-1002 drug had received Regenerative Medicine Advanced Therapy or RMAT, and orphan drug designations for the treatment of patients with Duchenne muscular dystrophy or DMD, which is a ...
- Edmonton firefighters camp out to extinguish muscular dystrophyon February 26, 2024 at 12:34 pm
A group of Edmonton firefighters are braving the cold weather on rooftops to raise money and awareness for muscular dystrophy.
- 'Funny, caring and charming' Durham lad wins award for looking after brother with muscular dystrophyon February 25, 2024 at 10:01 am
William Jackson, 16, received a President's Award from charity Muscular Dystrophy UK in honour of caring for his brother Louis - who is 12 and has Duchenne muscular dystrophy. William, who is a pupil ...
- Muscular Dystrophy: Symptoms, causes, diagnosis and treatmenton February 22, 2024 at 2:27 pm
Muscular Dystrophy (MD) stands as a collective term for a group of genetic disorders characterized by progressive weakness and degeneration of the muscles that control movement. This condition ...
via Bing News